In previous studies, it has been demonstrated that beta-amyloid and tau pathology are reduced in animal models of Alzheimer's disease when combined with magnetic resonance-guided focused ultrasound and intravenously injected microbubbles [151]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.